| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |